Statins Are Effective in the Long Term

Published Online: Monday, November 1, 2004

The results of a Nordic study, with a follow-up of 10 years, show that statins may decrease mortality rate and incidence of cancer in the long term. In the Scandinavian Simvastatin Survival Study (4S), which was launched in 1989, patients were randomly assigned to simvastatin or a placebo for 5 years. The 5-year 4S followup had demonstrated that simvastatin treatment reduced cardiovascular mortality by 36% and coronary mortality by 43%.

The long-term follow-up compared the 2221 patients who had taken simvastatin for 10 years with the 2223 patients who had initially received placebo and had started taking statins just 5 years ago. Overall, there was a 17% decrease in cardiovascular mortality and a 24% reduction in coronary mortality for the 10-year statin users, compared with the 5-year users. These latest results were published in the Lancet, August 26, 2004.

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues